Status:
UNKNOWN
Endovascular Denervation in Patients With Cancer Pain
Lead Sponsor:
Zhongda Hospital
Conditions:
Cancer Pain
Eligibility:
All Genders
25-75 years
Phase:
NA
Brief Summary
Endovascular arterial denervation (ED) is a minimally invasive technique which could reduce the occurrence of injury of visceral tissue or organs. As the principle of renal denervation (RDN), Radiofre...
Detailed Description
The multi-electrode catheter was consisted of six independent electrodes helically on a net structure, which could be set as the same energy and temperature for simultaneous multi-point ablation. A re...
Eligibility Criteria
Inclusion
- 25 to 75 years
- severe cancer pain with the visual analogue scores of no less than 7
Exclusion
- pregnant or intent to become pregnant within 1 year
- postural hypotension
- uncorrected coagulation dysfunction
- aortic aneurysm or dissection
- type 1 diabetes mellitus (T1DM)
- acute or severe systemic infection
- history of cerebral apoplexy or transient ischemic attack (TIA) in the past two weeks
- history of acute coronary syndrome in the past two weeks
- participants who are not suitable to be enrolled into the study assessed by the researchers
Key Trial Info
Start Date :
September 21 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03431922
Start Date
September 21 2017
End Date
September 1 2019
Last Update
February 13 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongda Hospital, Southeast University
Nanjing, Jiangsu, China, 210009